Exonate’s principal scientist, Dr Jennifer Batson, to present at The Bermuda Principles Impact on Splicing 2nd Annual conference 2018 (BPIS)

Dr Jennifer Batson will present ‘Developing inhibitors of VEGF-A alternative splicing into a clinical candidate to deliver a paradigm shift in the treatment of retinal vascular diseases’ at Impact on Splicing 2nd Annual Conference 2018 Exonate is developing eye drops to revolutionise current standard-of-care in the treatment of eye diseases Cambridge, UK – 20 February…